Optimizing the Clinical Supply Chain China is now the second-largest pharmaceutical market in the world, and with a more harmonized and efficient clinical trial approval process, it is seeing a…
Inceptua GroupNovember 30, 2020
In clinical trials, a Comparator drug, either an investigational or marketed product, is often required to determine the efficacy relative to a drug that is already on the market. Safe,…
Inceptua GroupMarch 22, 2020
Inceptua has been actively operating in China for almost 20 years and is continuing to expand capabilities throughout the APAC region. Our office in Shanghai is where our specialist China…
Inceptua GroupJuly 3, 2019
A comparator is an investigational or marketed product (active control) or placebo (inactive control) used as a reference in a clinical trial. The term also refers to investigational medicinal products…
Héloïse VimontJune 27, 2019
Rapid economic and demographic changes are causing a boom in the Chinese market for pharmaceuticals. This offers opportunities for pharma companies, but the landscape is complex, and understanding the changes…
Inceptua GroupJanuary 25, 2019
Inceptua’s Edoardo Madussi shares his insights The case in favour of running a global clinical trial is compelling: lower running costs, quicker timelines, and access to substantially larger patient populations…
Morten GrønNovember 1, 2018